Gemma Soler

Founded in Osaka in 1951, for over 70 years we have been dedicated to research, develop, manufacture, and distribute generic medicines to fulfill our Ikigai: Contribute to people’s health and generate genuine smiles. Towa is listed on the Tokyo Stock Exchange and is one of Japan’s main leading companies in its sector. In the current super-aged society, we make continuous efforts for stable supplies of generics that can help reduce users’ medical payments and counter increasing social security and medical costs while maintaining the quality of medical services. In addition to promoting stable supply, quality assurance, and information provision about generics, we focus on research and development of innovative initiatives to make our products easier to take and handle. To enter new markets, we also promote the construction of a structure that can provide Towa group’s added-value formulations to patients around the world through our overseas companies.